Inhibition of mINDY reduced hepatic lipid accumulation, improved hepatic insulin sensitivity, and prevented diet‐induced nonalcoholic fatty liver disease in adult C57BL6/J mice 27. The gene discussed is INS; the disease is metabolic dysfunction-associated steatotic liver disease.